New investor offers funding to healthy aging innovators

Latest articles

Exclusive: “Mitlets” hold potential for mitochondria transfusion

Mitrix Bio believes recently discovered blood components may support transfusion of large quantities of healthy mitochondria from donor to patient. Earlier this year, we brought...

Optimise your body and mind by tackling cell stress

Want to live longer and heathier? Combating cell stress is an important first step on your longevity journey. It's a fast-paced, busy world, and we're...

Crypto – pulling a (Moon) Rabbit out a hat for longevity

Angel Versetti on why it makes sense to look at more experimental solutions for longevity. Earlier this week we brought you part one of our...

New webinar will explore the opportunity of ovarian longevity

What does delaying menopause mean in terms of investment activity, societal change and the technologies that will reshape the lives of multiple millions of...

Most read

New supplement slows aging and promotes weight loss

Sugar-proof your way to a longer life. Reducing AGEs to slow aging and increase weight loss – how one supplement is fighting the war...

An antiaging supplement that also reduces appetite?

One for the AGEs: Juvify signs IP licensing deal with Buck Institute for GLYLO antiaging supplement that aims to reduce glycation. A researcher at the...

Resveratrol – the small molecule with big antiaging ideas

When it comes to antiaging molecules, we can learn a thing or two from plants. As so often in natural world, plants have a few...

Editor's picks

Exclusive: “Mitlets” hold potential for mitochondria transfusion

Mitrix Bio believes recently discovered blood components may support transfusion of large quantities of healthy mitochondria from donor to patient. Earlier this year, we brought...

Optimise your body and mind by tackling cell stress

Want to live longer and heathier? Combating cell stress is an important first step on your longevity journey. It's a fast-paced, busy world, and we're...

Crypto – pulling a (Moon) Rabbit out a hat for longevity

Angel Versetti on why it makes sense to look at more experimental solutions for longevity. Earlier this week we brought you part one of our...

Click the globe for translations.

A fifth investor has joined UK Research and Innovation (UKRI), providing matched funding for top small innovators to develop ideas for healthy aging.

The new investor in the healthy aging innovation is London-based Nesta; describing themselves as an “impact investor”, Nesta works on three missions: a fairer start, a healthy life and a sustainable future.

Longevity.Technology: The British Government is a great believer in the role technology can play in improving healthcare in the UK. However, many innovative companies lack the scale to bring real innovation to market. UKRI’s healthy aging investment partnership aims to inject the required capital to help some of the most promising businesses bring their innovations to market; the partnership does this by combining government funding and private investment in business-led research and development, supporting innovators to produce products and services for healthy aging that can be adopted at scale. Vitally, the government contribution de-risks the private sector investment, allowing cutting edge innovation to prosper.

The latest investor addition brings the total funding available under the programme to £18 million of grant funding and £18 million of equity investment available.

Lorraine Morley from Allia
Dr Lorraine Morley, UK Lead / Advisor for AgeTech Accelerator

Small and medium-sized enterprises can apply through one of two new and three original investor partners. In addition to Nesta, these now include: 24 Haymarket, Barclays Ventures, Northstar Ventures and Legal and General.

 


 

“NESTA could be a particularly strong ally as they unite the social impact and traditional investment worlds and these two elements need to be aligned if the age tech and healthy ageing market is to thrive…”

 


 

Nesta’s Chief Investment Officer, Nathan Elstub, said: “We are delighted to be able to work with UKRI to co-invest in the next generation of companies developing new ways of solving the challenge of ageing well.

“Their grant funding will enable us to support riskier, more cutting-edge approaches to this challenge and will be a perfect match for the patient capital in our impact investment work.”

George MacGinnis, Healthy Ageing Challenge Director at UKRI added: “Nesta’s investment in our partnership programme brings a new dimension to our portfolio with their mission to invest for good. This will broaden the opportunities available to support business growth.

“Nesta brings extensive experience of supporting social entrepreneurs to develop sustainable businesses that address some of the toughest challenges faced by an ageing society.”

We reached out to Dr Lorraine Morley, UK Lead / Advisor for AgeTech Accelerator and member of our own advisory panel for her take on the appointment.

“I am really pleased to hear that NESTA has been selected by UKRI as the latest joint-funding partner to support exciting and cutting-edge age tech businesses,” Dr Morley told us. “NESTA could be a particularly strong ally as they unite the social impact and traditional investment worlds and these two elements need to be aligned if the age tech and healthy ageing market is to thrive”.

Image credit: blank76Pixabay and Dr Lorraine Morley
Eleanor Garth
Deputy Editor Now a science and medicine journalist, Eleanor worked as a consultant for university spin-out companies and provided research support at Imperial College London and various London hospitals in a former life.

Most popular

New supplement slows aging and promotes weight loss

Sugar-proof your way to a longer life. Reducing AGEs to slow aging and increase weight loss – how one supplement is fighting the war...

An antiaging supplement that also reduces appetite?

One for the AGEs: Juvify signs IP licensing deal with Buck Institute for GLYLO antiaging supplement that aims to reduce glycation. A researcher at the...

Resveratrol – the small molecule with big antiaging ideas

When it comes to antiaging molecules, we can learn a thing or two from plants. As so often in natural world, plants have a few...

Tree of Longevity – understanding how supplements work

Pathways? Hallmarks? Biomarkers? Understanding the longevity supplements lingo can help you make better choices for your healthspan. Longevity supplements differ from other 'generic supplements' as...

Related articles

Crypto – pulling a (Moon) Rabbit out a hat for longevity

Angel Versetti on why it makes sense to look at more experimental solutions for longevity. Earlier this week we brought you part one of our...

New webinar will explore the opportunity of ovarian longevity

What does delaying menopause mean in terms of investment activity, societal change and the technologies that will reshape the lives of multiple millions of...

Buck Institute awarded $12.7m to join senescence network

NIH award to join SenNet, the Cellular Senescence Network, will enable Buck scientists to identify and characterise senescent cells – recognised as a driver...

Michael Antonov: longevity is all about tackling true unknowns

The Co-founder of Formic Ventures is using logic and innovation to drive the longevity sector forward. Michael Antonov is a serial entrepreneur and philanthropist who...

Shooting for the moon means going down the rabbit hole

Scientific co-operation, research collaboration and alternative financial incentives – Moon Rabbit is a crypto-conglomerate on a longevity mission. Moon Rabbit is on a mission to...